We are live on ! Find out more
CLLS

Cellectis
CLLS

43 hedge funds and large institutions have $181M invested in Cellectis in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

8% more funds holding

Funds holding: 40 → 43 (+3)

24% less capital invested

Capital invested by funds: $238M → $181M (-$56.9M)

Holders
43
Holders Change
+3
Holders Change %
+7.5%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
13
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tekla Capital Management
Massachusetts
+$3.96M
2
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$2.13M
3
VKH
Virtu KCG Holdings
New York
+$1.36M
4
BA
BlackRock Advisors
Delaware
+$1.29M
5
PA
Perceptive Advisors
New York
+$1.24M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.43M
2
GTC
Ghost Tree Capital
New York
-$1.67M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$1.15M
4
FMA
FNY Managed Accounts
New York
-$267K
5
Morgan Stanley
Morgan Stanley
New York
-$231K

CLLS Hedge Fund Activity: Q3 2015 in Review

43 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2015, worth a combined $181M — down 24% from $238M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CLLS positions and 4 closed out — a net gain of 3 holders — while 13 added to existing stakes and 10 trimmed.

The largest buyer was Tekla Capital Management, adding an estimated $3.96M. The largest seller was Millennium Management, cutting an estimated $2.43M.

  • 43 institutional investors held Cellectis (CLLS) as of Q3 2015, up from 40 in Q2 2015.
  • Funds reported $181M of Cellectis stock for Q3 2015, down 24% quarter-over-quarter.
  • 7 funds opened new Cellectis positions in Q3 2015 and 4 closed out, a net change of +3 holders.
  • The largest Cellectis buyer in Q3 2015 was Tekla Capital Management, an estimated $3.96M added.
  • The largest Cellectis seller in Q3 2015 was Millennium Management, an estimated $2.43M sold.

Based on aggregated 13F filings for Q3 2015.